Engineering Cancer | AIChE

Other Sites & Tools

Technical Groups

Engineering Cancer

Chair(s)

Ramsey, J., Oklahoma State University

Co-chair(s)

Zangle, T., University of Utah

This session highlights the contributions of chemical engineers who are changing the future of cancer diagnosis and treatment. This session explores exosomes, metastasis, development of drug resistance, evasion of the immune response, the impact of mass transport on tumor progression, dormancy, and recurrence and treatments for cancer including immunotherapy and precision medicine.

Presentations

3:30 PM
(233a) CRISPR-Mediated Rewiring of Epithelial-to-Mesenchymal Transition Regulatory Networks
3:50 PM
(233b) JNK-Inhibition Improves Viability in Cytidine-Analog-Treated Melanoma Cells
4:10 PM
(233c) ?-Glucan Induced Innate Immune Memory Alters the Tumor Microenvironment and Enhances Checkpoint Inhibitor Therapy
4:30 PM
(233d) A Multi-Scale, Optimization-Based Approach to Understanding Sulfur Fates in Integrated Biological and Transport Systems.
4:50 PM
(233e) Quantitative Phase Imaging with Patient Derived Models for Cancer Treatment Optimization
5:10 PM
(233f) Characterization of the Nano-Scale Surface Roughness of Living Cancer Cells Using a Non-Invasive Interference-Based Approach
5:30 PM
(233g) Unmethylated Plasmid DNA Delivery Boosts Survival Against Murine Melanoma

Topics 

Medicine
Biomedical Engineering
Biological Engineering

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00

More Conference Links